top of page

Publications

How Do We Increase Treatment for Alcohol Use Disorder in Primary Care? It Takes a Team

J Gen Intern Med. DOI: 10.1007/s11606-025-09939-z.

Jacob Weiss, Tyler Varisco, Jarratt D Pytell

Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel

Drug Alcohol Depend Rep. DOI: 10.1016/j.dadr.2025.100360

Tyler J Varisco, Douglas Thornton, Taha Hussain, Hannah Fish, Joshua Bolin, David Dadiomov, Ekere J Essien, Matthew A Wanat, Diane Ginsburg, Jeanne Waggener, Jeffrey P Bratberg, Bethany DiPaula, Lucas G Hill; PhARM-OUD Working Group

Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs

Drug Alcohol Rev. DOI: 10.1111/dar.70035

Olajumoke A Olateju, Tyler Varisco, Scott Weiner, Douglas Thornton

Prediction of Antipsychotic Associated Weight Gain in Children and Adolescents Taking Second Generation Antipsychotics: A Machine Learning Approach

J Psychiatr Res. DOI: 10.1016/j.jpsychires.2025.09.068

Ning Lyu, Ying Lin, Paul J Rowan, Susan Abughosh, Tyler J Varisco, Hua Chen

Gaps in buprenorphine access: Examining provider availability and treatment continuity

Journal of Substance Use and Addiction Treatment. DOI: 10.1016/j.josat.2025.209818

Abolfazl Sadeghi, J. Douglas Thornton, Tyler J. Varisco

In Support of a Public Health Approach to Drug Policy: Position Statement of AMERSA, Inc

Subst Use Addctn J. DOI: 10.1177/29767342251381162

Katherine Hill, Tessa L Rife-Pennington, Claire Zagorski, Katherine Dunham, Kimberly L Sue, Corey Davis, Michael Incze

Wound care practices among people who inject drugs in Austin, Texas

Substance Use Addctn J. DOI: 10.1177/29767342251334203

McCullough HP, Kane H, Cance J, Tatum C, Loera LJ, Kmetz L, Hill LG

Over-the-Counter Naloxone and Nonprescription Syringe Availability in Community Pharmacies

JAMA Netw Open. DOI:10.1001/jamanetworkopen.2024.58095

Loera LJ, Lines JE, Mayberry SR, Hilzendager SA, Ferguson AP, Hill LG.

Relationships between stigma, risk tolerance, and buprenorphine dispensing intentions among community-based pharmacists: Results from a national sample

Subst Use Addctn J. DOI: 10.1177/29767342231215178.

Light AE, Green TC, Freeman PR, Zadeh PS, Burns AL, Hill LG.

Research priorities for expansion of opioid use disorder treatment in the community pharmacy

Subst Use Addctn J. DOI: 10.1177/08897077231203849.

Jarrett JB, Bratberg J, Burns AL, et al.

bottom of page